X

Online Education

ASCPT is pleased to offer complimentary access to live and recorded educational resources, as a benefit to its members.  You must be logged in as a member to view these materials.

Upcoming Webinars:
ASCPT Webinar presented by the Special Populations (SPO) Community and Regulatory Science (RS) Community
Title:  Pediatric Master Protocols: Clinical Pharmacology Challenges and Opportunities
Date and Time: Monday, October 7, 2019, 1:00 pm ET
Speakers and Panelists: Luna Musib, PhD, Elimika Pfuma Fletcher, PharmD, PhD, and Nita Seibel, MD
Moderators: Anuradha Ramamoorthy, PhD
Description: This special session will focus on opportunities, considerations and challenges related to pediatric master protocols. The speakers will discuss pharmacogenomic and other clinical pharmacology considerations for master protocols. Examples of pediatric master protocols will be highlighted. The pharmacogenomic discussion will highlight considerations for patient selection and treatment allocation based on molecular subsets of disease. The session will also include a moderated panel discussion, including a clinician involved in the NCI Pediatric MATCH trial.
https://register.gotowebinar.com/#register/4299107357330724867

Past webinars:
 Title Speaker(s) Recording and/or Presentation Slides Primary Audience
Perfecting Your ASCPT Meeting Experience How to Make the Most of Your First ASCPT Annual Meeting Brian Corrigan, PhD Webinar Recording ASCPT 2019 Annual Meeting
How to Develop and Qualify Biomarkers  Biomarker Consortium Perspective
Joseph P. Menetski, PhD Webinar Recording  CTS Journal
2018 ITC Update on Clinically-Relevant Transporters, Clinical Probes, and DDI Evaluation
Maciej Zamek-Gliszczynski, PhD
 Webinar Recording CPT Journal
Endogenous Biomarkers of Membrane Transporters and Model Based Prediction of Clinic Kenta Yoshida, PhD
Xinning Yang, PhD
 Webinar Recording PSP Journal
ASCPT Abstracts – Everything You Need to Know Kellie Schoolar Reynolds, PharmD Webinar Recording
Webinar Transcript
Annual Meeting
Member Orientation Webinar Sponsored by Cytel
Jin Yan Jin, PhD Webinar Recording ASCPT New Members
New Member Welcome Jin Yan Jin, PhD Webinar Recording
Presentation Slides
ASCPT New Members
2018 Scientific Proposals - Secrets to Success Virginia (Ginny) D. Schmith, PhD, FCP Webinar recording
Presentation Slides
 ASCPT Members
New Member Welcome Webinar for 2017 Annual Meeting Attendees
Jin Yan Jin, PhD
Webinar Recording
Presentation Slides

New ASCPT Members
How to Participate in the ASCPT 2017 Annual Meeting
  Webinar Recording
Membrane Transporter
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics France Mentré
Webinar Recording ASCPT Journal Family
Driving Patient-Centered Translational Medicine
Christopher P. Austin, MD
Webinar Recording
ASCPT Journal Family
Implementing Pharmacogenetic Tests for Patient Care Using Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guidelines
Mary V. Relling, PharmD
Webinar Recording
ASCPT Journal Family
Journal Club "Comparison of Genome Sequencing and Clinical Genotyping for Pharmacogenes"
Wenjian Yang Webinar Recording
*presentation only, no audio
Presentation slides
Pharmacogenomics
Pharmacokinetics and Dose Adjustments for Monoclonal Antibodies in IBD - Considerations and Applications in Clinical Practice
Diane Mould, PhD
Anne Strik, MD
Webinar Recording
Presenters' responses to attendee questions 
ASCPT Journal Family

For all past webinars please visit the ASCPT Webinar Library.

ASCPT Members-Only Webinar presented by the Biologics Community
Title:  Development of Talimogene Laherparepvec, First FDA Approved Genetically Modified Oncolytic Virus: Perspectives of Clinical Pharmacology
Date and Time: Tuesday, October 29, 2019, 2:00 pm ET
Speakers and Panelists: Matt Hsu, PhD, Sumita Bhatta, MD, and Xiaofei Wang, PhD
Moderators: Yow-Ming Wang, PhD
Description: Talimogene laherparepvec is an oncolytic virus-based therapeutic product that is derived from herpes simplex virus type 1 (HSV-1). It has been genetically modified to efficiently replicate within tumors and to enhance systemic antitumor immune responses by producing the immune stimulatory protein granulocyte-macrophage colony-stimulating factor (GM-CSF). Clinical pharmacology program of talimogene laherparepvec was designed to characterize the kinetics of viral clearance through biodistribution in the blood and urine, shedding from injected tumors and exterior of the dressing, anti-HSV-1 seroconversion, and GM-CSF expression in tumor tissue and serum. This special presentation will provide an introduction of genetically modified products and regulatory advances in this field, as well as challenges and clinical pharmacology support of talimogene laherparepvec development pathway.
Registration Link: 
https://attendee.gotowebinar.com/register/2000518926673682691
Check back for more information about ASCPT Replay.

ASCPT thanks the members of its Webinar Committee for its efforts in developing strong, meaningful informational and educational materials, which are accessible to ASCPT members in an online format. Submit your idea for a webinar.

Photo Gallery
Recent News
Contact Us